HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing innovative immunotherapies for cancer and infectious diseases. Founded in 2011, HOOKIPA has made significant strides in the field, particularly with its proprietary platform that harnesses the power of viral vectors to stimulate robust immune responses. The company operates primarily in the oncology and infectious disease sectors, offering unique therapies that stand out for their ability to target specific antigens effectively. HOOKIPA's lead product candidates, including its promising therapies in clinical trials, exemplify its commitment to advancing treatment options. With a strong market position and notable achievements in research and development, HOOKIPA Pharma continues to be at the forefront of biopharmaceutical innovation, striving to improve patient outcomes globally.
DitchCarbon Score
How does HOOKIPA Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HOOKIPA Pharma Inc.'s score of 18 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
HOOKIPA Pharma Inc.'s reported carbon emissions
HOOKIPA Pharma Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of data does not preclude the company from engaging in climate initiatives or setting future targets. As the biopharmaceutical industry increasingly focuses on sustainability, HOOKIPA Pharma may align with industry standards and practices to address climate change. Further information on their climate strategies or commitments may be disclosed in future reports.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HOOKIPA Pharma Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
